Overview of the Post:
Branca Bunús Ltd., a spin-out company of University College Dublin (UCD) in Ireland; Prof Wenxin Wang’s Lab, located in the Charles Institute of Dermatology, School of Medicine at University College Dublin (UCD) in Ireland, is seeking motivated, passionate candidates to embark on PhD doctoral studies in the fields of polymer chemistry, or non-viral gene delivery polymeric material, or robotic/automatic platform development (working with us for high throughput chemical synthesis and cell work).
Organization: Branca Bunús Ltd. and University College Dublin (UCD)
Workplace: Nova UCD, Belfield Innovation Park, Dublin, D04 V2P1, Ireland; Prof. Wenxin Wang’s lab, The Charles Institute of Dermatology, School of Medicine, UCD, Ireland.
Post Treatment and Cultivation Mode: This is a 4-year full-time position with a stipend of €18,000 per annum and a PhD fee contribution of €14,700 per annum. PhD students are encouraged to engage in diversified industry and technology transfer activities and go to internationally renowned research groups or R&D enterprises in their research field for collaborative research study and medical product development.
Research Field:
Polymer Chemistry/Gene therapy/Gene Delivery/Nanotechnology/Robotic/automatic platform
Company and Group Website:
https://brancabunus.com/;
http://www.wenxinwang.group/
Introduction to Branca Bunús Ltd.:
Branca Bunús was incorporated in Nov 2019 by spinning out from UCD, aiming to develop and commercialize nonviral gene therapy products to treat genetic diseases and develop advanced academic and industrial transfection reagents based on our polymer patent family (licensed from UCD and newly expended) for patients and medical professionals spread worldwide. Prof Wenxin Wang is the co-founder of the company.. BRB has established the pipeline to bring its unique corrective in vivo nonviral polymer gene therapy product (IP licensed from UCD) to the market for RDEB therapy. BRB has a solid scientific and technical team combining chemical, biological, and regulatory expertise and has (1) office space and access to a GMP-like chemistry lab and cleanroom in the NovaUCD Innovation Centre; (2) access to all the research facilities in UCD and office and laboratory space at Charles Institute of Dermatology and Conway Institute.
Introduction to Prof Wenxin Wang and Wang’s lab:
Prof. Wenxin Wang is currently Full Professor at the Charles Institute of Dermatology, School of Medicine, University College Dublin (UCD), a member of UCD Academic Council. Prof. Wang and his research group has long been engaged in the research of controlled polymerization mechanism, the design and synthesis of novel functional biomaterials and their applications in bone, cartilage, and skin wound healing. As the basis of all following synthesis and application research regarding multifunctional biomaterials, the kinetically controlled mechanism behind the controlled polymerization of multifunctional monomers is always the core research direction in Prof. Wang’s research group. In recent years, through the combination of experiment, theory and computer simulation, Prof. Wang has been committed to systematically studying the controlled mechanism of multifunctional monomer polymerization, revealing the polymerization process, understanding and establishing the universal theory of multifunctional monomer polymerization to provide theoretical guidance for the synthesis of architecturally complex polymers.
Prof. Wang’s scientific contributions and achievements have been recognized extensively at the global level, reflected from the over 210 peer-reviewed scientific journal papers (Science Advances, Nature Communications, Nature Reviews Chemistry, JACS, Angewandte Chemie, Advanced Materials, Nano Letters, Macromolecules, etc.), 5 book chapters, 34 patents, 140 conference abstracts and presentations, and 113 invited lectures and keynote presentations. His achievements have met the increased interest in the wider public community with publicity media activities (engaging 56 times in TV Documentary, Videos and Newspapers), for example, in ‘The Sunday Times’, ‘The Irish Times’, ‘Science Daily’ and ‘Chemistry World’. He has been awarded significant funding (over 11.4 million Euros) from different sources to support his research activities. Prof. Wang acted as the symposium convener and chair, the member of organizing committees and the member of the conference advisory board for 31 international conferences and has been selected as an expert reviewer and panel member by 26 international research councils and funding bodies. As the founder, Prof Wang has launched 3 companies - Vornia Ltd (www.vornia.com, sold to Ashland - a Fortune500 US company in Jan. 2018, renamed as Ashland Specialties Ireland), Blafar Ltd (www.blafar.com), Branca Bunus Ltd (www.brancabunus.com). Furthermore, he has licensed 17 new technologies to 5 companies and successfully launched and commercialized 5 newly developed technologies onto the market.
Post Requirements:
1. A Master's degree in Polymer Chemistry / Gene therapy/ Gene Delivery/ Nanotechnology or other related fields.
2. A strong passion for Science, particularly technology transfer, based on solid theoretical research.
3. A high level of competence in the English language. UCD's minimum English language requirements: An average score of 6.5 over all components and a minimum of 6.0 in each band on the Academic Version/A minimum score of 90 is required in the Internet-based TOEFL (iBT) with a score of at least 20 in each section/ Due to COVID-19, UCD has approved the use of 1he Duolingo English Test (DET) as a temporary measure for the 2022 intake. The minimum requirement will be a DET score of 110.
4. Highly motivated, driven, creative, conscientious, and can work independently and integrate as part of a team.
5. Healthy, kind, nice, decent, honest, and hard-working.
We are committed to cultivating a group of high-quality talents who are truly passionate in the field of polymeric science and advanced gene delivery technology. The team will be passionate from fundamental science to its technology transfer and commercialization, bringing techniques to industrial and medical uses, benefiting society.
We warmly and sincerely welcome new blood to join our big family!
Application procedure:
If you would like to apply, please send your CV and Personal Statement to [Email Address Removed] and [Email Address Removed] or [Email Address Removed] with the subject line ‘PhD application’. Your application will be judged openly and fairly. We will contact the short-listed candidates for preliminary assessment and following interviews as soon as possible.
Continue with Facebook
